GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » Other Operating Expense

Orion Pharma (DHA:ORIONPHARM) Other Operating Expense : BDT1,034 Mil (TTM As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma Other Operating Expense?

Orion Pharma's Other Operating Expense for the three months ended in Mar. 2025 was BDT3 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was BDT1,034 Mil.

Orion Pharma's quarterly Other Operating Expense declined from Sep. 2024 (BDT5 Mil) to Dec. 2024 (BDT0 Mil) but then increased from Dec. 2024 (BDT0 Mil) to Mar. 2025 (BDT3 Mil).

Orion Pharma's annual Other Operating Expense declined from Jun. 2022 (BDT1,002 Mil) to Jun. 2023 (BDT996 Mil) but then increased from Jun. 2023 (BDT996 Mil) to Jun. 2024 (BDT1,036 Mil).


Orion Pharma Other Operating Expense Historical Data

The historical data trend for Orion Pharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma Other Operating Expense Chart

Orion Pharma Annual Data
Trend Dec14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 820.75 879.38 1,002.46 995.54 1,036.01

Orion Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.16 1,025.14 4.85 0.26 3.46

Orion Pharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT1,034 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orion Pharma Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Orion Pharma's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Pharma Business Description

Traded in Other Exchanges
N/A
Address
153-154 Tejgaon Industrial Area, Orion House, Dhaka, BGD, 1208
Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma Headlines

No Headlines